# PsyMed Ventures

> PsyMed Ventures is a San Francisco venture firm backing early-stage companies at the intersection of brain health, mental health and frontier technology. Founded in 2020, it grew from a psychedelic-medicine podcast and AngelList syndicate into a specialist fund investing across neurotechnology, precision neuroscience, AI-enabled care, novel therapeutics, digital health and science-led consumer products.

- **Founded:** 2020
- **Headquarters:** San Francisco, United States
- **Founders:** Matias Serebrinsky (Co-Founder and General Partner), Greg Kubin (Co-Founder and General Partner), Dina Burkitbayeva (Co-Founder)
- **Team size:** LinkedIn lists 17 associated employees while the company profile states 2-10 employees; the operating team shown on PsyMed's website is small and supplemented by venture partners and advisors.
- **Products:** PsyMed Ventures Fund I, PsyMed Ventures Fund II, PsyMed AngelList Syndicate, Business Trip, Future Neuro Founders Workshop
- **Notable:** Built an AngelList syndicate that Crunchbase reported had invested $15.6 million across 14 companies with more than 300 participating LPs by January 2022., Reported $15 million in signed commitments for Fund I in April 2023., Launched Fund II in 2025 and reported three investments from it by November 2025.

## Products & services

- **PsyMed Ventures Fund I** — An early-stage specialist venture fund for psychedelic medicine, neurotechnology, digital health, precision neuroscience and related mental-health technologies.
- **PsyMed Ventures Fund II** — A $25 million offering focused on frontier neuroscience, brain health, mental health and human augmentation; the firm said it began investing from the fund in 2025.
- **PsyMed AngelList Syndicate** — A deal-by-deal investment vehicle that preceded the institutional funds and connected hundreds of accredited investors with mental-health startups.
- **Business Trip** — PsyMed's podcast and research channel covering brain health, mental health, founders, scientists and emerging technologies.
- **Future Neuro Founders Workshop** — A founder program run with KdT Ventures; the 2025 edition drew more than 400 founders.

## Achievements

- Built an AngelList syndicate that Crunchbase reported had invested $15.6 million across 14 companies with more than 300 participating LPs by January 2022.
- Reported $15 million in signed commitments for Fund I in April 2023.
- Launched Fund II in 2025 and reported three investments from it by November 2025.
- Reported that Fund I was performing in the top decile for its vintage as of November 2025; this is a firm-reported, unaudited performance claim.
- Backed companies across RNA medicines, CRISPR-enabled live biotherapeutics, focused ultrasound, precision psychiatry, digital therapeutics, virtual reality and AI-enabled care.
- Ran a second Future Neuro Founders program with KdT Ventures in 2025, reporting participation from more than 400 founders.
- Built Business Trip into a recurring podcast and research channel covering founders and scientists in brain and mental health.

## Latest updates

- **2026-07** — Published its 'State of Frontier Neuroscience' thesis, arguing that scientific tools, pharma demand and the brain-health crisis are making more neuroscience companies venture-backable.
- **2026-05** — Published a Business Trip episode on brain organoids, space research and implications for AI.
- **2026-04** — Published an investment landscape on digital addiction and highlighted portfolio company Jimini Health's $17 million seed round.
- **2026-02** — Published an analysis of whole-brain emulation by investment associate Danny Carbonero.
- **2025-11** — Said it was investing from Fund II, had made three investments, and that Fund I ranked in the top decile for its vintage; these are firm-reported claims.
- **2025-09** — Announced an investment in Aerska as part of a $21 million round to develop RNAi therapies designed to cross the blood-brain barrier.

## Links

- Website: https://psymed.ventures
- LinkedIn: https://www.linkedin.com/company/psymed-ventures
- Twitter/X: https://twitter.com/PsymedVentures

---

Profile page: https://yespress.io/psymed-ventures
Published by YesPress — https://yespress.io
Last updated: 2026-08-16